Alkem Laboratories Limited – NSE:ALKEM.NS

One share of Alkem Laboratories Limited stock can currently be purchased for approximately $3,641.1.

Unfortunately, Alkem Laboratories Limited's (ALKEM.NS) next earnings date is currently unknown.

Yes, Alkem Laboratories Limited pays dividends and its trailing 12-month yield is 0.73% with 0% payout ratio. The last Alkem Laboratories Limited stock dividend of $0 was paid on 12 Sep 2025.

Alkem Laboratories Limited has a market capitalization of 655.44B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 20.51% to 126.68B US dollars.

Alkem Laboratories Limited is traded on the NSE under the ticker symbol "ALKEM.NS".

Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

Shares of Alkem Laboratories Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

Alkem Laboratories Limited's management team includes the following people:

• Mr. Basudeo Narian Singh Executive Chairman(age: 84, pay: $159,300,000)
• Mr. Sandeep Derjit Singh MD & Executive Director(age: 43, pay: $117,200,000)
• Mr. Mritunjay Kumar Singh Executive Director(age: 62, pay: $76,900,000)
• Mr. Balmiki Prasad Singh Executive Director(age: 71, pay: $56,100,000)
• Mr. Sarvesh Singh Vice President of Sales & Marketing and Executive Director(age: 43, pay: $34,900,000)

As Dec 2024, Alkem Laboratories Limited employs 17,432 workers, which is 3% more then previous month and 3% more then previous quarter.

Alkem Laboratories Limited is publicly traded company for more then 9 years since IPO on 23 Dec 2015.

The official website for Alkem Laboratories Limited is alkemlabs.com.

Alkem Laboratories Limited can be reached via phone at +91 22 3982 9999.